| Adverse effects: 2k. Specific ‐ movement disorder ‐ iii. average scores ‐ i. up to 24 hours | |||||
|---|---|---|---|---|---|
| Study | Intervention | Mean | SD | N | Notes |
| endpoint score at 24 hours (SAS, high=worse) ‐ (skewed data) | |||||
| Eli Lilly 2004 | Haloperidol | 1.4 | 2.8 | 22 | |
| Eli Lilly 2004 | Olanzapine | 2.2 | 3.5 | 20 | |
| endpoint score at 24 hours (BAS, high=worse) ‐ (skewed data) | |||||
| Eli Lilly 2004 | Haloperidol | 1.5 | 1.7 | 22 | |
| Eli Lilly 2004 | Olanzapine | 1.7 | 2.6 | 20 | |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.